✦ LIBER ✦

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu

✍ Scribed by Rathindranath Baral; Amanda Sherrat; Ruma Das; Kenneth A. Foon; Malaya Bhattacharya-Chatterjee

Publisher: John Wiley and Sons
Year: 2001
Tongue: French
Weight: 341 KB
Volume: 92
Category: Article
ISSN: 0020-7136
DOI: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1148>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bispecific monoclonal antibody therapy (

Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu

✍ Frank H. Valone; Peter A. Kaufman; Michael W. Fanger; Paul M. Guyre; Clark Sprin 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

One of the most critical issues regarding management of early breast cancer is the proper detection and correct estimation of its malignant potential. In recent years, primarily through mammography, the frequency of ductal carcinoma in situ (DCIS) in malignant breast biopsies has increased several f

Induction of cellular immune responses b

Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791tgp72 antigen expressed on colorectal, gastric and ovarian human tumours

✍ Lindy G. Durrant; Mark Doran; Eric B. Austin; R. Adrian Robins 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 525 KB

There is accumulating evidence that cellular rather than antibody responses are more effective for tumour rejection. It is therefore important to screen anti-idiotypic (anti-id) antibodies for their ability to stimulate anti-tumour T-cell responses. The human anti-id monoclonal antibody (MAb) I05AD7